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a b s t r a c t
Although forming a heterodimer or heterooligomer is essential for MDM2 and MDMX to fully control
p53 during early embryogenesis, deletion of either MDM2 or MDMX in speciﬁc tissues using the loxp-
Cre system reveals phenotypic diversity during organ morphogenesis, which can be completely rescued
by loss of p53, suggesting the spatiotemporal independence and speciﬁcity of the regulation of p53 by
MDM2 and MDMX. In this study, we investigated the role of the MDM2–MDMX-p53 pathway in the
developing lens that is a relatively independent region integrating cell proliferation, differentiation and
apoptosis. Using the mice expressing Cre recombinase speciﬁcally in the lens epithelial cells (LECs)
beginning at E9.5, we demonstrated that deletion of either MDM2 or MDMX induces apoptosis of LEC
and reduces cell proliferation, resulting in lens developmental defect that ﬁnally progresses into aphakia.
Speciﬁcally, the lens defect caused by MDM2 deletion was evident at E10, occurring earlier than that
caused by MDMX deletion. These lens defects were completely rescued by loss of two alleles of p53, but
not one allele of p53. These results demonstrate that both MDM2 and MDMX are required for
monitoring p53 activity during lens development, and they may function independently or synergis-
tically to control p53 and maintain normal lens morphogenesis.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Embryonic development of lens originates from the surface
ectoderm, and is driven by a series of inductive signals. This
process comprises regional speciﬁcation events and coordinated
differentiation, starting from the induction of the lens placode, a
single layer of thickening cells, through the physical contact of
optic vesicles with the overlying ectoderm at mouse embryonic
day 9.5 (E 9.5), followed by invagination at E 10 to form a lens pit
and further detachment from the rest of the ectoderm to become a
lens vesicle. Next, the posterior epithelial cells of the vesicle
elongate, denuclearize and differentiate into primary lens ﬁbers
to ﬁll up the vesicle cavity at E 12.5, The secondary lens ﬁbers
eventually develop from differentiated anterior epithelial cells in
the equatorial zone on the margins of the lens epithelia that
undergo proliferation and inward migration while the anterior
cells in the center of the epithelium remain largely quiescent
(Graw, 1996; Pan et al., 2010; Wride, 1996). Once the lens epithelial
cells initiate terminal differentiation, they withdraw from the cell
cycle and elongate into lens ﬁber cells, undergoing denucleation,
and loss of other cellular organelles. The mature lens retains a
single layer of undifferentiated epithelial cells on its anterior
surface (Graw, 1996). All the cellular events crucial for lens
morphogenesis, including cell proliferation, migration and differ-
entiation, are tightly controlled by the inductive interaction and
sequential activation of transcription factors. As one of the most
important lens-bias and lens-speciﬁcation factors, Pax6 is exp-
ressed broadly in the head ectoderm including the presumptive
lens ectoderm prior to contact with the optic vesicle (Ashery-
Padan and Gruss, 2001; Klimova and Kozmik, 2014; Shaham et al.,
2012), and it regulates the expression of other transcriptional
factors or miRNAs during lens induction, such as Six3, Sox2, FoxE3,
L-Maf, Prox1 and miR-204, which are implicated in the formation
of the lens placode and vesicle and/or subsequent lens ﬁber
differentiation (Ashery-Padan and Gruss, 2001; Kamachi et al.,
2001; Ogino et al., 2012; Purcell et al., 2005; Shaham et al., 2013;
Smith et al., 2009). In a feedback fashion, some of these transcrip-
tion factors, such as Six3 and Sox2, also mediate Pax6 expression
(Liu et al., 2006; Ogino et al., 2012; Smith et al., 2009), suggesting a
coordinated interaction of the lens-speciﬁc proteins to determine
the spatio-temporal order of the occurrence of cell proliferation
and differentiation during lens morphogenesis. Cell apoptosis also
plays a crucial role during lens development. Apoptosis assists the
morphogenetic process of the lens vesicle and the detachment of
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the lens vesicle from the ectoderm (Yan et al., 2006). Activation of
the apoptosis signals, such as Apaf-1, Bcl-2 family members,
caspase family members and endonuclease, is necessary for lens
denucleation and differentiation (Geatrell et al., 2009; Yan et al.,
2006). Denucleation of lens ﬁber cells is an apoptosis-like process,
but unlike apoptotic cells, denucleated ﬁber cells persist through-
out life to form mature lens, rather than being destroyed and
eliminated (Geatrell et al., 2009; Pan and Griep, 1995).
As one of the most important tumor suppressors, p53 induces
cell cycle arrest, apoptosis, autophagy and senescence through
transactivation of many cell death and survival related protein-
encoding genes, including p21, Bax, Puma, and so on (Boominathan,
2010; Lane and Levine, 2010), or transcription-independent
mechanisms (Leung and Sharp, 2010). Genetic studies have shown
that p53 is not essential for normal embryonic development
(Donehower et al., 1992; Jacks et al., 1994). However, mice with
inactive or deﬁcient p53 displayed incomplete lens ﬁber cell
denucleation (Jean et al., 1998; Pan and Griep, 1994; Wiley et al.,
2011), and failed to induce the regression of the primary vitreous
during eye development (Reichel et al., 1998), resulting in a high
frequency of cataracts. Likewise, abnormal induction of apoptosis in
lens epithelial cells promotes the cataractogenesis caused by
oxidative stress (Mok et al., 2014), UV irradiation (Ayala et al.,
2007; Godar, 1996; Xiao et al., 2012), diabetes (Takamura et al.,
2003; Ye et al., 2013) and aging (Zheng and Lu, 2011), which could
be p53-dependent (Yan et al., 2006). These studies indicate that
tight control of p53 level and activity and subsequent cell death is
crucial for lens development and pathology.
To prevent the detrimental effects of p53 on cell growth,
cells recruit two physiological inhibitors of this protein, MDM2
(called HDM2 in human) and MDMX (also called MDM4, an
MDM2 analog), so that p53 activity is restrained below an unde-
tectable level in most of the normal cells under normal conditions
(Chen et al., 1993; Kawai et al., 2007; Kruse and Gu, 2009; Linke
et al., 2008; Momand et al., 1992; Oliner et al., 1993; Wade et al.,
2010). Both MDM2 and MDMX directly inhibit p53’s transcriptional
activity by binding to the transactivation domain of p53 with similar
afﬁnities (Shadfan et al., 2012). MDM2, but not MDMX, can also act
as an E3 ubiquitin ligase to mediate p53 protein degradation (Kruse
and Gu, 2009). Although both MDM2 and MDMX null mice died at
the early stage of embryonic development due to p53 over-activa-
tion, loss of MDM2 in embryos caused the lethality at implantation,
which occurred several days earlier than the lethality due to MDMX
deletion (Montes de Oca Luna et al., 1995; Parant et al., 2001),
suggesting the regulation of p53 by MDM2 and MDMX during
embryogenesis may vary in a temporal and tissue-speciﬁc manner. It
has been indicated that MDM2 forms a heterodimer or heterooli-
gomer with MDMX through their C-terminal domains to inhibit p53
during early embryogenesis (Huang et al., 2011; Pant et al., 2011;
Sharp et al., 1999; Tanimura et al., 1999). However during later
developmental stages of organ morphogenesis and adult life, MDM2
and MDMX may independently or cooperatively regulate p53 to
delicately control cell proliferation, differentiation and death so that
each organ maintains unique shape and function, which is sup-
ported by the more severe phenotypes observed with conditional
deletion of MDM2 in cardiomyocytes (Grier et al., 2006; Xiong et al.,
2007), central nervous system (Xiong et al., 2006) and smooth
muscle cells (Boesten et al., 2006), compared to those with loss of
MDMX. Besides p53, pRB (retinoblastoma protein) is another major
tumor suppressor that executes its function by controlling G1 phase
and cell proliferation (Weinberg, 1995), and deletion of Rb gene or
abnormal expression of pRB has been highly related to several
human tumors including retinoblastoma (Clarke et al., 1992; Dyer
et al., 2005; Jacks et al., 1992; Lee et al., 1992). Loss of Rb also causes
lens developmental defects due to unchecked proliferation, impaired
differentiation and p53-dependent apoptosis in lens ﬁber cells
(Morgenbesser et al., 1994). It has been shown that MDM2 accel-
erates pRB protein degradation through both ubiquitin-dependent
and -independent manners (Miwa et al., 2006; Uchida et al., 2005),
but surprisingly, MDMX binds to pRB to inhibit MDM2 mediated
pRB downregulation (Uchida et al., 2006). All these previous studies
suggest that MDM2 and MDMX could be crucial during lens
development and lens disease progression to control the lens cell
proliferation, differentiation and cell death, by targeting either p53
or pRB, or both. To address this issue, in the current study we take
advantage of the mice with MDM2 or MDMX conditional alleles and
deleted MDM2 or MDMX gene by crossing them with the mice
expressing Cre beginning at E9.5 under the control of the Pax6
enhancer speciﬁcally in both lens epithelial progenitors and pan-
creatic endocrine progenitors (LE-Cre) (Ashery-Padan et al., 2000,
2004). Interestingly, we found that loss of MDM2 results in a more
severe phonotype even though both MDM2 and MDMX are required
to maintain normal lens development by controlling p53 activity,
and provided evidence for the tissue speciﬁc difference in the roles
of MDM2 and MDMX in development. Also, we found that homo-
zygous loss of p53, but not Rb, alleles can completely rescue the
defects of lens development caused by deleting either MDM2 or
MDMX, indicating that p53, but not Rb, is the downstream target of
MDM2 or MDMX, leading to lens dysmorphogenesis.
Materials and methods
Mouse lines and ethics statement
The MDM2FL/FL, MDMXFL/FL, p53FL/FL, RbFL/FL and Le-Cre transgene
mouse lines were described previously (Ashery-Padan et al., 2000;
Grier et al., 2006; 2002; Jonkers et al., 2001; Marino et al., 2000), and
individually maintained with homozygotes. Brieﬂy, the Le-Cre trans-
gene expression starts at around E9, and the Cre-mediated recombi-
nation is evident since E9.5 in most cells of the surface ectoderm, and
subsequently in the SE-derived eye structures including the develop-
ing lens, cornea, conjuctiva, skin of the eyelids and pancreatic
endocrine precursors (Ashery-Padan et al., 2000). To obtain the mouse
lines with MDM2 or MDMX speciﬁc deletion in developing lens,
Le-Cre mice were crossed with either MDM2FL/FL or MDMXFL/FL
homozygotes, then Le-Cre; MDM2FL/þ or Le-Cre; MDMXFL/þ hetero-
zygous offsprings were further crossed with MDM2FL/FL or MDMXFL/FL
homozygotes, respectively. Le-Cre; MDM2FL/FL and Le-Cre; MDMXFL/FL
mice were compared with MDM2FL/þ and Le-Cre; MDM2FL/þ mice, or
MDMXFL/þ and Le-Cre; MDMXFL/þ , respectively. To obtain Le-Cre;
MDM2FL/FL; p53FL/FL mice, Le-Cre; MDM2FL/þ were ﬁrst crossed with
p53FL/FL mice, then Le-Cre; MDM2FL/þ; p53FL/þ offsprings were
further crossed with MDMXFL/þ; p53FL/þ offspring. To obtain Le-Cre;
MDMXFL/FL; p53FL/FL mice, Le-Cre; MDMXFL/FL mice were ﬁrst crossed
with p53FL/FL mice, then Le-Cre; MDM2FL/þ; p53FL/þ offsprings were
further crossed with MDMXFL/þ; p53FL/þ offsprings. The mice from
these breeders were recruited in the experiments as shown in Fig. 6,
including MDM2FL/FL (or MDMXFL/FL); p53FL/FL, Le-Cre; MDM2FL/FL
(or MDMXFL/FL); p53FL/þ , and Le-Cre; MDM2FL/FL (or MDMXFL/FL);
p53FL/FL mice. The Le-Cre; MDMXFL/FL (or MDM2FL/FL); RbFL/FL mouse
line was obtained through a similar mating strategy as described
above. Their genotypes were determined by PCR analysis of the
genomic DNA extracted from their tails. For the embryo collection,
noon of the day of vaginal plug observation was considered as E0.5 of
embryogenesis. For BrdU staining, 200 mg/kg body weight of BrdU
was administrated to mice via intraperitoneal injection 2 h before
their embryos were harvested.
All animal experiments were conducted in accordance with the
National Institutes Health “Guide for the Care and Use of Labora-
tory Animals” and were approved by the Institutional Animal Care
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and Use Committee at Tulane University School of Medicine and
our animal protocol number is 4257.
Antibodies and reagents
Antibodies used in the study include rabbit polyclonal anti-p53
(ﬂ393, Santa Cruz, 1:100 for immunostaining), rabbit polyclo-
nal anti-Pax6 (PRB-278P, Convance, 1:200 for immunostaining),
mouse monoclonal anti-MDM2 (SMP14, Santa Cruz, 1:50 for
immunostaining), rabbit polyclonal anti-BrdU (Santa Cruz, 1:100
for immunostaining) and mouse monoclonal anti-Ki67 (BD, 1:100
for immunostaining). The ﬂuorescein In situ cell death detection
kit was purchased from Roche.
H&E staining
Mouse embryos were isolated and rinsed with PBS, followed by
ﬁxation with 4% PFA overnight, serial dehydration and parafﬁn
embedding. Parafﬁn blocks were then cut into 8 μm-thick sec-
tions, and subjected to hematoxylin/eosin staining to determine
possible morphological changes. Basically, 8 μM-thick tissue sec-
tions underwent regular deparafﬁnization and rehydration, and
then were dipped into Hematoxalin solution for 3 min and Eosin
solution for 45 s, followed by dehydration in 70%, 95% and 100%
ethanol and xylene. The slides were ﬁnally covered with perma-
nent mounting medium (Vector Laboratories, CA) and stored at RT,
and scanned using a microscope equipped with a digital camera
(Zeiss 200) with a 10objective.
Immunohistochemistry
Immunohistochemistry was performed with 6 μM-thick cryo-
sections. Brieﬂy, mouse embryos were ﬁxed in 4% PFA, put into
30% sucrose overnight, embedded with O.C.T, and cut into 6 μm-
thick sections. The cryosections were boiled in fresh citrate buffer
(10 mM Sodium Citrate, 0.05% Tween-20, pH 6.0) using a steamer
for 40 min for antigen retrieval. After being blocked with blocking
buffer (5% Goat serum, 0.3% TritonX-100 in 1 PBS) for 1 h at RT,
the sections were incubated with primary antibodies in a humid
chamber at 4 1C overnight followed by incubation with Alexa 488
or 594-conjugated goat-anti mouse or goat-anti rabbit IgG sec-
ondary antibodies (Biorad) at RT for 30 min, then the sections
were washed with 1PBS for 3 times, and covered with anti-
fading buffer. For some immunoﬂuorescence staining, the sections
were incubated with HRP-conjugated goat-anti mouse or goat-anti
rabbit IgG secondary antibody after incubation with a primary
antibody, and then subjected to FITC tyramide signal ampliﬁcation
(TSA)-plus or cyanine 3 (Cy3) TSA-plus (PerkinElmer) incubation
for 10 min to amplify the signal. Images were obtained under a
ﬂuorescence microscope (Zeiss 200) with a 20 objective. Cell
proliferation was measured as the ratio of BrdU or Ki67-positive
cells to DAPI-positive cells in lens epithelia by one-way ANOVA
analysis. Four mice per group were recruited to obtain statistical
signiﬁcance.
TUNEL staining
Apoptosis was also determined by in situ TUNEL staining, using
the Fluorescein In situ cell death detection kit (Roche) according to
manufacturer’s instructions. Brieﬂy, the cryosections were permea-
bilized in permeabilisation buffer (0.1% TritonX-100, 0.1% sodium
citrate) at RT for 5 min, followed by incubation with TUNEL reaction
mixture at 37 1C for 1 h, and mounted with anti-fading buffer after
rinsing with PBS. Images were obtained under a ﬂuorescence
microscope equipped with a digital camera (Zeiss 200) with a
20 objective.
Fig. 1. Loss of MDM2 causes developmental defects of lens. (A) Genotyping analysis for Le-Cre overexpression and MDM2 ﬂoxed allele using the genomic DNA abstracted
from mouse tails. (B) Table showing that loss of MDM2 in both lens epithelium and pancreatic endocrine cells does not lead to embryonic lethality, but causes eyeless
phenotype, and neonatal lethality. (C) Images showing that MDM2 deletion causes lens developmental defects as evident at E10, and anophthalmia after birth. Top: Images
of eyes isolated from neonatal mice. Mid-upper: H&E staining of embryonic eye structure at E12.5. Mid-lower: DAPI staining of embryonic lens structure at E10. Dashed areas
indicate the lens pit. Bottom: Merged image of Pax6 immunoﬂuorescence staining and DAPI counterstaining. Arrows indicate the presumptive lens ectoderms at E9.5. Scale
bars: 100 μM.
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Statistics
Data were reported as means7SEM with N being the sample
size. Comparisons among different groups were conducted by
using One-way ANOVA. Probability values of Po0.05 were con-
sidered statistically signiﬁcant.
Results
Loss of MDM2 causes developmental defects of lens
To obtain mice with MDM2 deletion speciﬁcally in developing
lens, we ﬁrst crossed Le-Cre; MDM2FL/þ with MDM2FL/FL mice as
described in the Methods section, and the genotypes of their
offsprings were determined by PCR analysis as shown in Fig. 1A.
Four genetic types of pups including Le-Cre; MDM2FL/FL, Le-Cre;
MDM2FL/þ , MDM2FL/FL and MDM2FL/þ , were obtained with a
normal Mendelian ratio as shown in Fig. 1B, indicating the deletion
of MDM2 in developing eyes and pancreas didn’t cause embryonic
lethality. However, all the Le-Cre; MDM2FL/FL pups developed
hyperglycemia with random blood glucose level higher than
400 mg/dl (data not shown), and died within one week after birth
(Fig. 1B). In this study, we only focused on lens morphogenesis, as
the pancreatic phenotypes will be reported separately. We found
that deletion of MDM2 ﬂoxed alleles by Le-Cre results in severe lens
dysmorphogenesis. At E9-9.5, the surface ectoderm competent for
the presumptive lens was roughly normal in Le-Cre; MDM2FL/FL
compared to MDM2FL/þ , MDM2FL/FL or Le-Cre; MDM2FL/þ mice
(bottom panels in Fig. 1C), as indicated by the immunoﬂuoresence
staining of Pax6. However, at E10 the lens placode was unable to
develop into lens pit in the MDM2 deletion mice as indicated by
DAPI staining (mid-lower panels of Fig. 1C). At E12.5, the lens vesicle
was formed in control mice, but in the MDM2 conditional knockout
mice by contrast, the lens tissues disappeared completely, and the
eye space was ﬁlled up with twisted retina (mid-upper panels of
Fig. 1C). After birth, intact eyes developed normally in the control
group, but aphakia was seen in all the MDM2-null mice (top panels
of Fig. 1C). Since there was no obvious lens defect observed in
Le-Cre; MDM2FL/þ , MDM2FL/þ and MDM2FL/FL (data not shown), we
combined the three groups as a control afterward (Fig. 1C). Together,
these results indicate that loss of MDM2 during embryogenesis
causes irreversible defects of lens development as early as E9.5-10,
leading to congenital aphakia.
Loss of MDMX causes developmental defects of lens
Since previous studies demonstrated that loss of MDM2 or
MDMX causes developmental defects with tissue speciﬁcity
(Boesten et al., 2006; Grier et al., 2006; Hilliard et al., 2011; Xiong
et al., 2007, 2006), we also wanted to determine whether lens would
undergo dysmorphogenesis when the MDMX gene is knocked out in
the developing lens by using the same genetic approach as described
above. After MDMXFL/FL mice were crossed with Le-Cre; MDMXFL/þ
mice, 4 genetic types of pups, including Le-Cre; MDMXFL/FL, Le-Cre;
MDMXFL/þ , MDMXFL/FL, and MDMXFL/þwere obtained with a normal
Mendelian ratio (Fig. 2A and B). No aberrant eye-related phonotypes
were observed in adult Le-Cre transgenic or Le-Cre; MDMXFL/þ mice
(Fig. 2B and C). Interestingly, unlike Le-Cre; MDM2FL/FL mice, Le-Cre;
MDMXFL/FL mice were viable, but eyeless (Fig. 2B). Histological
analysis showed that the lens pit is formed normally in conditional
MDMX deletion mice at E10. However, the development of lens
vesicle was delayed at E10.5, and the shape of their lens vesicle cells
was dramatically narrower and thinner than that of the control
group (Fig. 2C). Even though the development of their retinae was
Fig. 2. Loss of MDMX causes developmental defects of lens. (A) Genotyping analysis for MDMX ﬂoxed allele using the genomic DNA abstracted from mouse tails. (B) Table
showing that loss of MDMX in lens epithelium causes eyeless phenotype. (C) Images showing that MDMX deletion causes lens developmental defects that starts at around
E10.5 and anophthalmia after birth. Top: Images of adult mice showing eyeless phenotype in MDMX knockout mice. Mid-upper: H&E staining of embryonic eye structure at
E14.5. Middle: H&E staining of embryonic eye structure at E12.5. Mid-lower: H&E staining of embryonic eye structure at E10.5. Solid line areas indicate the lens pits. Bottom:
DAPI staining of embryonic lens structure at E10. Scale bars: 100 μM.
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relatively normal, lens development was completely blocked at E12.5
and ﬁnally progressed into aphakia at adulthood (Fig. 2C). In
addition, loss of MDMX might exert some effect on the development
of other eye structures such as eyelids, suggested by the closed
eyelids in the MDMX knockout mice (Fig. 2C). These results
demonstrate that loss of MDMX during embryogenesis causes
retardation of lens morphogenesis at around E10.5, leading to adult
aphakia similar to that of mice with MDM2 deletion.
p53 Level is elevated in the developing lens lacking MDM2 or MDMX,
and well correlated with induced apoptosis and inhibited
proliferation
As described above, MDM2 and MDMX are two physiological
inhibitors of p53 and work together as a complex and/or inde-
pendently to control p53 level and activity by directly blocking
p53’s transactivational activity and promoting its ubiquitination-
dependent proteasomal degradation, in a spatial-temporally spe-
ciﬁc manner. Thus, we wanted to determine if p53 is induced in
the lens tissue lacking either MDM2 or MDMX. Indeed, the p53
level was markedly increased in the lens epithelial cells of E10
embryos without MDM2 gene, whereas p53 was undetectable in
the control mice, as shown by the immunoﬂuorescence staining in
Fig. 3A. Likewise, loss of MDMX also induced p53 protein level
dramatically in the lens epithelial cells as early as E10 when the
Le-Cre was shown to be expressed at a high level (Ashery-Padan
et al., 2000). The expression of Pax6, which is highly expressed in
the ectoderm and developing lens, didn’t display any change upon
MDM2 or MDMX deletion (Fig. 3A and B), indicating that the lens
induction and differentiation that are mediated by this transcrip-
tional factor during early embryogenesis was not affected by loss
of either MDM2 or MDMX. Of note, we used FITC TSA-plus (at E10)
or Cy3 TSA-plus ﬂuorescence system (at E10.5 and E11) to enhance
the p53 signal induced by MDMX deletion (Fig. 3B right), other-
wise the signal would be undetectable by our regular immuno-
ﬂuorescence staining procedure. On the contrary, p53 signal was
easy to be detected in the MDM2 deleted lens epithelial cells,
implying that a much higher level of p53 was induced by loss of
MDM2 than that by loss of MDMX.
To further investigate if p53 activation in MDM2 and MDMX
deﬁcient lens might lead to any cellular consequences, such as cell
death and proliferation, we then assessed cell apoptosis by TUNEL
assay and the cell proliferation rate by BrdU incorporation assay.
As shown in Fig. 4A and B, cell apoptosis was remarkably induced
in the defective lens epithelial cells of both MDM2 and MDMX
knockout mice, but could not be detected in the control lens.
Similarly, the cell proliferation rate decreased from around 75% to
28% in the MDM2 deleted mouse lens at E10, and from 68% to 50%
in the MDMX deleted mouse lens at E10.5 (Fig. 5A and B). These
results indicate that p53 is over-activated in both MDM2 and
MDMX deﬁcient lens tissues, consequently leading to aberrant cell
apoptosis and impaired cell proliferation during lens development.
Fig. 3. p53 is induced in the lens lacking MDM2 or MDMX. (A) Immunoﬂuorescence staining of PAX6 (left) and p53 (right) in the lens with or without MDM2 expression at
E10. Dashed areas indicate the expression of PAX6 in lens (red color), and arrow indicates the expression of p53 in lens (red color). (B) Immunoﬂuorescence staining of PAX6
(left) and p53 (right) in the lens with or without MDMX expression at E10, E10.5 and E11. Dashed areas indicate the expression of PAX6 in lens (red color). Arrows indicate
the expression of p53 in lens (red or green color). Scale bars: 100 μM.
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Loss of p53, but not Rb, rescues the lens developmental defects of
conditionally MDM2- or MDM4-deleted mice
As mentioned before, earlier studies showed that MDMX
regulates RB protein level by blocking the MDM2-mediated RB
degradation (Uchida et al., 2006), suggesting the possible involve-
ment of RB in the MDM2 or MDMX deletion-caused lens defects.
To test this possibility, we generated MDM2/RB and MDMX/RB
lens-speciﬁc double knockout mice. As shown in Fig. S1, loss of RB
exerted no evident effects on either MDMX or MDM2 deletion-
mediated lens defects (Fig. S1). MDMX/RB double knockout mice
developed the same eyeless phenotype as that observed in MDMX
single knockout mice. Also, MDM2/RB double knockout mice died
within 1 week after birth with defective lens. Although we didn’t
further investigate if RB deletion could affect the onset of lens
defects during embryogenesis or not, these results at least indicate
that RB deregulation is not the causative factor for lens dysmor-
phogenesis observed in MDM2 or MDMX deﬁcient mice.
Because p53 is the most important target of MDM2 and MDMX
(Kruse and Gu, 2009; Wade et al., 2010), and activated in the
MDM2- or MDMX-deleted lens epithelial cells (Fig. 3), we tested if
the activated p53 might be the cause for the cell death, prolifera-
tion abnormalities and subsequent developmental defects of lens
in the MDM2- and MDMX-deleted mice by introducing p53 ﬂoxed
alleles into MDM2 or MDMX conditional knockout mice and
deleting p53 gene by Le-Cre. The genotype of p53 ﬂoxed allele
was identiﬁed by PCR (Fig. 6A), and the loss of p53 protein
expression was conﬁrmed by the immunoﬂuorescence staining
(Figs. 7 and 8. As expected, the lens defect caused by either MDM2
or MDMX knockout was completely rescued by p53 deletion.
Similar to the control mice, the lens pit was formed at E10 in
MDM2 deleted mice and the lens vesicle was formed and detached
from the ectoderm at E12.5 in MDMX deleted mice, which ﬁnally
developed into normal eye structure in the adult mice with
MDM2/p53 or MDMX/p53 double knockout (Fig. 6B–D, Fig. 1B
and C, Fig. 2B and C). However, loss of one copy of p53 seemed not
to be enough to counteract the MDMX or MDM2 deletion caused
eye defects (Fig. 6B–D). In addition, loss of two copies, rather than
one copy, of p53 completely rescued the MDM2 mediated neonatal
lethality from pancreatic development defects (Fig. 6B), which will
not be discussed in this study.
Consistently, the MDM2/p53 or MDMX/p53 double knockout
lens epithelial cells did not display any detectable cell apoptosis
(Figs. 7 and 8A and the cell proliferation rate restored to around
75% in both MDM2/p53 and MDMX/p53 double knockout lens
epithelia at E10 or E12.5, similar to that of the control mice, as
shown in Figs. 7 and 8B. Taken together, these results demonstrate
that p53 activation, leading to induction of cell death and inhibi-
tion of proliferation, is the main reason for the lens developmental
abnormality in either MDM2 or MDMX conditional null mice.
Discussion
The fact that systemic deletion of MDM2 or MDMX causes
p53-dependent embryonic lethality at very early stages indicates
the indispensability and non-redundancy of both MDM2 and
MDMX and their tight regulation on p53 during embryogenesis
(Montes de Oca Luna et al., 1995; Parant et al., 2001). Even though
the interaction or complex formation between MDM2 and MDMX
Fig. 4. Cell apoptosis is induced in the lens lacking MDM2 or MDM4. (A) TUNEL staining using the cryosections of embryonic eyes with or without MDM2 expression at E10.
(B) TUNEL staining using the cryosections of embryonic eyes with or without MDMX expression at E10.5. In both panel A and B, dashed areas indicate the embryonic lens
structure, and green color denotes the TUNEL positive cells as indicated by arrows. Scale bars: 100 μM.
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has been shown to be essential for controlling p53 level and
activity during early embryogenesis (Huang et al., 2011; Pant et al.,
2011), more subtle studies using loxp-Cre system demonstrate that
difference may exist between MDM2 and MDMX on controlling
p53 to maintain the balance of cell death and proliferation, and
ensure the normal development and function of different tissues
Fig. 5. Cell proliferation is inhibited in the developing lens lacking MDM2 or MDM4. (A) Co-immunoﬂuorescence staining of BrdU and PAX6 in the embryonic lens lacking
MDM2 expression at E10 (left). BrdU positive cells in lens epithelium were counted under microscope (right) to assess the cell proliferation, and 4 mice per group were
recruited in this assay. (B) Co-immunoﬂuorescence staining of BrdU and PAX6 in the embryonic lens lacking MDMX expression at E10.5 (left). BrdU positive cells in lens
epithelia were counted under a microscope (right) to assess cell proliferation, and 4 mice per group were recruited in this assay. In both A and B, dashed areas indicate the
embryonic lens structure. Scale bars: 100 μM.
Fig. 6. Loss of p53 rescues the developmental defects of lens caused by deletion of MDM2 or MDM4. (A) Genotyping analysis for p53 ﬂoxed allele using the genomic DNA
abstracted frommouse tails. (B) Table showing that loss of two alleles of p53 in lens epithelium completely rescues the eyeless phenotype caused by MDMX deletion (upper)
or MDM2 deletion (lower). (C) Upper: Images of adult mice with the indicated genotypes. Lower: DAPI staining of the cryosections of embryonic eyes with indicated
genotypes at E12.5. (D) Upper: Images of adult mouse or eyes isolated from P1 neonates with the indicated genotypes. Lower: DAPI staining of the cryosections of embryonic
eyes with indicated genotypes at E10. In both (C) and (D), dashed areas indicate the embryonic lens structure. L: Lens. Scale bars: 100 μM.
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under different physiological and pathological conditions (Boesten
et al., 2006; Grier et al., 2006; Xiong et al., 2007, 2006). Lens
development is a relatively independent process integrating cell
proliferation, differentiation and apoptosis, which provides an
ideal system to investigate more clearly the regulation of MDM2
and MDMX on p53, and the delicate cooperation and different
responsibilities of these two p53 regulators during development.
In the current study, we demonstrate that both MDM2 and MDMX
are indispensable to maintain the early embryonic development of
lens. Deletion of either MDM2 or MDMX in lens epithelium by the
loxP-Cre system results in abnormal cell apoptosis and impaired
cell proliferation, and consequently irreversible lens defects and
aphakia which can be completely rescued by the loss of p53.
Notably, compared to the lack of MDMX, MDM2 deletion-caused
lens developmental deﬁciency happens earlier. This difference
might be because that though both MDM2 and MDMX have been
shown to bind the transactivation domain of p53 with similar
afﬁnities and to inhibit p53 activity equivalently (Bottger et al.,
1999), the former also possesses an intrinsic E3 ubiquitin ligase,
and thereby can mediate p53 proteasomal turnover perhaps
independently of MDMX in vivo in a tissue-speciﬁc and embryonic
stage-speciﬁc fashion (Boesten et al., 2006; Grier et al., 2006;
Haupt et al., 1997; Kubbutat et al., 1997; Michael and Oren, 2003;
Pant et al., 2011). The different actions between MDM2 and MDMX
on p53 might also account for their differential roles in organo-
genesis during development as further discussed below.
Biochemical studies have demonstrated that MDM2 and MDMX
interact with each other directly through their RING domains
(Tanimura et al., 1999). Through mechanisms that still remain
debated, MDMX is shuttled from the cytoplasm into the nucleus
(Elias et al., 2005; Gu et al., 2002; Li et al., 2002; Migliorini et al.,
2002), where it binds to and works together with MDM2 to
inactivate p53 (Li et al., 2003; Wang and Jiang, 2012). The physiolo-
gical importance of this MDM2–MDMX binding in monitoring p53
level and activity is elegantly validated by two genetic studies. These
studies show that disruption of the MDM2–MDMX interaction or
dissociation of the complex by knocking in a mutant MDMX that is
unable to bind to MDM2, but retains its ability to bind to p53, leads
to high p53 activation during mouse embryogenesis, causing vast
apoptosis, impaired cell proliferation, and consequent lethality at
E9.5, which could be completely rescued by homozygous deletion of
TP53 (Huang et al., 2011; Pant et al., 2011). In contrast to this general
role in embryogenesis, MDM2 and MDMX appear to play an
independent role in speciﬁc organ formation and function main-
tenance. This is revealed by several conditional knockout studies. For
example, conditional inactivation of MDM2, but not MDMX, in
embryonic heart by α-MHC Cre led to cardiac development abnorm-
alities and embryonic lethality (Grier et al., 2006). By contrast, loss of
MDMX in heart was not embryonic lethal, instead resulted in dilated
cardiomyopathy in adult mice and shorter longevity (Xiong et al.,
2007). Also, deletion of MDM2, but not MDMX, in some quiescent
cells, such as terminally differentiated smooth muscle cells (SMCs),
Fig. 7. Loss of p53 rescues the abnormal apoptosis and restores the cell proliferation in the lens epithelium lacking MDM2. (A) Top: Immunohistochemistry staining of
MDM2 at E10 to conﬁrm the deletion of MDM2 mediated by Le-Cre expression. Solid line areas indicate the lens pits. Middle: Immunoﬂuorescence staining of p53 at E10.
Bottom: TUNEL staining of the cryosections of embryonic eyes at E10. (B) Co-immunoﬂuorescence staining of BrdU (green) and PAX6 (red) using the cryosections of
embryonic eyes with indicated genotypes at E10. BrdU positive cells in lens epithelia were counted under a microscope to assess cell proliferation, and 4 mice per group were
recruited in this assay. Scale bars: 100 μM.
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contributed to severe cell loss and rapid death (Boesten et al., 2006).
Deletion of MDM2 or MDMX in the central nervous system led to
hydranencephaly at E12.5 or proencephaly at E17.5 (Xiong et al.,
2006). Furthermore a latest study indicates that the regulation of
MDM2 on p53 is tissue-speciﬁc in adult mice and becomes blunt
with aging, suggesting the difference of p53 controlling by its
inhibitors exists between embryogenesis and adulthood (Zhang
et al., 2014). Regardless of the phenotype diversity, all the defects
caused by MDM2 or MDMX deletion can be completely rescued by
concomitant deletion of TP53, indicating that the functional differ-
ence and tissue speciﬁcity of MDM2 and MDMX are p53-dependent.
Our study as presented here adds another example of these
differences in terms of the role MDM2 or MDMX plays in embryonic
organogenesis. Speciﬁcally, even though both MDM2 and MDMX
deletion caused lens developmental defects, the phenotype occurred
earlier in MDM2-null eyes than that of MDMX-null eyes (Figs. 1
and 2). Again these defects of lens development were completely
rescued by the loss of p53, demonstrating that a tight control of p53
level and activity by both MDM2 and MDMX is also essential for
normal lens morphogenesis. Also, MDMX possesses non-redundant
function of MDM2 on p53 regulation during lens development, and
neither of them can compensate the loss of the other. The observa-
tion of more severe and earlier lens defect resulting from lack of
MDM2 than that from lack of MDMX suggests that MDM2 and
MDMX are able to suppress p53 by different ways, separately or
synergistically, more than forming a complex, which is also indicated
by the much stronger p53 signal induced by MDM2 deletion than
that induced by MDMX deletion, as mentioned in the result section
(Fig. 3). Further studies using conditional knock-in strategy of MDMX
or MDM2, which eliminates the binding of MDM2 and MDMX,
meanwhile maintains their function on p53, would help further
illustrate the independence and interaction of MDM2 and MDMX in
regulation of p53 during development and function maintenance of
all speciﬁc tissues.
Previous studies showed that MDM2 and MDMX can also regulate
pRB protein level (Miwa et al., 2006; Uchida et al., 2006, 2005). Lack of
Rb expression in lens ﬁber cells induced p53 dependent apoptosis and
consequent lens defects (Morgenbesser et al., 1994). These studies
suggest that pRB may be one of the factors that could link MDM2 or
MDMX to lens development. We thus also tested this possible link
in vivo. However, we did not observe any obvious effect of Rb deletion
on the defects of lens formation caused by either MDMX or MDM2
deletion (Fig. S1). Our study demonstrates that p53, but not pRB, is the
reason for why MDM2 or MDMX deletion causes dysmorphogenesis
of lens. Our study also suggests that pRB might not interplay with
these two p53 inhibitors during embryonic lens development, even
though we didn’t investigate if either MDM2 or MDMX deletion could
inﬂuence the expression of pRB in developing lens.
Abnormal p53 expression has been linked to pathogenesis of
certain eye diseases. Excess p53 levels induced by ultraviolet (UV)
Fig. 8. Loss of p53 rescues the abnormal apoptosis and restores the cell proliferation in the lens epithelium lacking MDMX. (A) Top: Immunoﬂuoresence staining of PAX6 at
E12.5. Middle: Immuno-ﬂuorescence staining of p53 at E12.5. Bottom: TUNEL staining of the cryosections of embryonic eyes at E12.5. (B) Co-immunoﬂuorescence staining of
Ki67 (green) and PAX6 (red) using the cryosections of the embryonic eyes with indicated genotypes at E12.5. Ki67 positive cells in lens anterior epithelia were counted under
a microscope to assess cell proliferation, and 4 mice per group were recruited in this assay. Solid line areas indicate the lens anterior epithelia. Scale bars: 100 μM.
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radiation or galactose exposure result in improper apoptosis of lens
epithelial cells (LECs), which is the major mechanism underlying the
UV-caused, or galactosemic and diabetic cataracts (Ayala et al., 2007;
Godar, 1996; Takamura et al., 2003; Xiao et al., 2012; Ye et al., 2013).
Deﬁciency of some genes required for normal lens development,
such as OREBP and Ncoa6, induces DNA strand breaks and cell cycle
arrest, resulting in incomplete elongation and differentiation of lens
ﬁber cells and nuclear cataract, due to the activation of p53 (Wang
et al., 2010; 2005). On the other hand, lack of p53 in lens leads to the
accumulation of the ﬁber cells in the posterior plaques, and then the
ﬁber cells continue to proliferate and fail to withdraw from the cell
cycle to form proper terminal differentiated ﬁber cells (Wiley et al.,
2011). Consistently, p53 may play a role in preventing the formation
of steroid- or radiation-induced posterior subcapsular cataracts by
suppressing the improper proliferation of ﬁber cells and promoting
the death of the ﬁber cells that enter the cell cycle (Wiley et al.,
2011). Besides the cataracts, over-activated p53 and subsequent
apoptosis of LECs have also been suggested to be associated with
microphthalmia/anophthalmia caused by some genetic deﬁciency
(Hettmann et al., 2000; Jaramillo-Rangel et al., 2013). In line with
these previous studies, our study as presented here also identiﬁed
the essential role of the p53 pathway in aphakia. Although the exact
mechanism underlying the aberrant activity of p53 during the
progression of some eye diseases remains unknown, it is likely that
p53 is uncontrollable by its most important regulators MDM2 and
MDMX under some pathological conditions, as suggested by this
study. Binding to MDM2 and/or MDMX is the most essential step for
p53 to be regulated. Disrupting the interaction between p53 and
these two inhibitors has become an intriguing strategy for develop-
ing cancer therapy (Issaeva et al., 2004; Reed et al., 2010; Shangary
et al., 2008; Vassilev et al., 2004), and it has been implicated in many
pathological progressions of normal tissues as well (He et al., 2014;
Hilliard et al., 2011; Liu et al., 2014; Xiong et al., 2007). For example,
as identiﬁed by our previous studies and other groups, DNA damage
causes phosphorylation of MDMX, followed by enhanced binding of
14-3-3 to phosphorylated MDMX, leading to the release of p53 from
MDMX and subsequent activation of p53 (He et al., 2014; Jin et al.,
2006; Wang et al., 2009). Also, ribosomal stress could be another
outcome of DNA damage (Antoniali et al., 2014; Lim et al., 2013;
Nalabothula et al., 2010), which further induces the binding of
ribosomal proteins to MDM2, resulting in the disassociation of
MDM2 and p53, and subsequent p53 activation (Dai and Lu, 2004;
Sun et al., 2007; Zhang and Lu, 2009; Zhang et al., 2003). Inability of
MDM2 or MDMX to restrain p53 through the above-mentioned
pathways might be the underlying mechanisms by which DNA
damage or other lesions activates p53 during the progression of
some p53-related ophthalmic disorders, such as some types of
cataract and microphthalmia. Further studies are needed to eluci-
date these possibilities and hypotheses.
In summary, this study demonstrates for ﬁrst time that both
MDM2 and MDMX are necessary to maintain the normal morpho-
genesis of lens, and loss of either of them causes aberrant activation
of p53 and subsequent cell apoptosis, leading to lens defects, which
cannot be compensated by the existence of any single one of the
two p53 inhibitors. This suggests that MDM2 and MDMX function
independently or synergistically during lens development to control
p53, more than forming a hetero-complex. The signiﬁcance of the
MDM2/MDMX/p53 pathway could also be highlighted in some p53-
related ophthalmic disorders, including microphthalmias and catar-
acts, but deserve further investigation in the near future.
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